Navigation Links
Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
Date:6/8/2009

that blinatumomab and BiTE antibodies, in general, may have in fighting cancer," said Micromet's Senior Vice President and Chief Medical Officer, Carsten Reinhardt, M.D.

(1) Klinger, M. et al. (2009). Pharmacodynamic analyses of peripheral blood from relapsed B-NHL patients treated with anti-CD19/-CD3 bispecific BiTE(R) antibody blinatumomab. 14th Congress of EHA, abstract number 430

(2) Bargou, R. et al. (2008). Sustained Response Duration Seen after Treatment with Single Agent Blinatumomab (MT103/MEDI-538) in the Ongoing Phase I Study MT103-104 in Patients with Relapsed NHL. ASH 2008, abstract number 267

Webcast/Conference Call

Micromet will host a webcast/conference call this morning from 9:00 am to 11:00 am U.S. Eastern time to discuss the blinatumomab data presented at the 14th Congress of the European Hematology Association. The webcast will be available on the company's website at www.micromet-inc.com. To participate in the conference call, dial 866-543-6403 (U.S.) or 617-213-8896 (international), passcode: 12594792.

A replay of the call will be available from 1:00 pm Eastern Time on June 8, 2009 (7:00 pm Central European Time) through June 15, 2009. The replay number is 888-286-8010 (U.S.) or 617-801-6888 (international), passcode: 67386852.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class of antibodies that activate the T cells of a patient's immune system to eliminate cancer cells. Four of Micromet's antibodies are currently in clin
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
4. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
5. Micromet Key Events for 2009
6. Micromet Expands Committed Equity Financing Facility to $75 Million
7. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
8. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
9. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... Chief Executive Officer, has been elected to the Company,s ... Steven G. Anderson , Executive Chairman of CryoLife, stated, ... to be an excellent leader who is well positioned ...
(Date:10/22/2014)... JERUSALEM , October 22, 2014 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused ... today reported positive top-line clinical results from its ... proprietary oral insulin capsules, to treat type 1 ... United States under a U.S. Food ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms of ... or unnoticed, but new technology, coupled with yearly, ... leading to earlier detection of eye diseases, including ... million Americans. If left untreated, these diseases can ... Recently, optometric researchers have deployed ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... CVM ) reports financial results for the fiscal ... operating loss for fiscal year 2007 of $9,352,209,versus a ... The loss per,share for fiscal year 2007 was unchanged ... from operating activities used during the year was about,$4,890,100. ...
... Fla., Jan. 11 Florida Atlantic,University and Scripps ... on Wednesday, January 16 from 4-5:30 p.m. in ... Blobel, M.D., Ph.D.,is the 1999 recipient of the ... D. Rockefeller, Jr. Professor, The Rockefeller University, and,Investigator, ...
Cached Medicine Technology:CEL-SCI Corporation Announces 2007 Financial Results 2CEL-SCI Corporation Announces 2007 Financial Results 3Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University 2Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University 3
(Date:10/25/2014)... home safe and sound is one of the best Halloween ... costumes and goody bags have reflective strips that improve visibility ... at Meadowlands Hospital Medical Center in Secaucus, N.J. ... flame-resistant, Davis said. He offers these others tips: ... a small area of skin first to ensure it doesn,t ...
(Date:10/25/2014)... October 25, 2014 The ... which verifies IT-accessibility for disabled users by disabled ... logo to Mackin Educational Resources of Burnsville, ... management system and to the Minnesota Alliance for ... "Own Best Medicine" website. Both organizations ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... Oct. 23, 2014 (HealthDay News) -- Current osteoporosis ... younger postmenopausal women at risk for osteoporosis-related fractures, ... to prevent fractures, we need tools that help ... injuries so that we can target these at-risk ... Crandall, professor of medicine in the division of ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
... Diabetic retinopathy is the most common disorder seen in diabetics. ... a person with diabetes develops diabetic retinopathy,// a major cause ... diabetes is responsible for 7 percent of legal blindness, making ... adults 22 to 70 years old. ,Researchers from the ...
... can block the death of brain cells in mice who ... (HD), which is a rare degenerative brain disorder //caused by ... may be one step closer to a treatment, according to ... treated with a bile acid known as tauroursodeoxycholic acid (TUDCA), ...
... shows people with diabetes who are in a happy ... unhappily married counterparts. Researchers from the State University of ... adults with diabetes who had been married for an ... insulin, were surveyed again two years after the initial ...
... the University in Boston, a person's degree of inhibition when ... tied to his or her likelihood of being overweight. The ... low-calorie foods--can help people who just can't seem to resist ... B. Roberts. The reasons why some people are able to ...
... According to a new study, it has been found ... as you age. Mental decline is not a specific part ... are typically living longer. The ability to know, think, learn ... of life and survival in older ages. Researchers from the ...
... cancer all over the world. More than 30,000 women ... breast cancer this year. Researchers now believe small family ... fueling this ever-growing epidemic.// ,Researchers from England ... information on breastfeeding and childbearing patterns. Together, the studies ...
Cached Medicine News:Health News:Stop and think before you eat 2Health News: Breastfeeding may decrease Breast Cancer Risk 2
The ultimate replacement device, the Contour MD ICD offers a maximum stored energy of 42 J. The device delivers high-energy defibrillation output and is ideal for patients with maximum energy defibri...
... a key participant in the area of ... decade. Previous Medtronic autotransfusion systems allowed clinicians ... well as to determine requirements for a ... (PRP) for a small amount of autologous ...
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0...
... catheters comprise the world's broadest line ... procedures. Their advanced catheter design and ... response with a soft, atraumatic tip. ... sizes, Supreme and Response catheters provide ...
Medicine Products: